1 day Ago By ABMN Staff
Shares of Doximity, Inc. ( NASDAQ:DOCS – Get Free Report ) have been assigned an average recommendation of “Hold” from the fourteen research firms that are covering the firm, Marketbeat.com reports.
Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and four have given a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $32.42.
A number of equities analysts recently commented on DOCS shares. Robert W. Baird lifted their target price on shares of Doximity from $41.
00 to $45.00 and gave the stock an “outperform” rating in a research report on Tuesday. Truist Financial reiterated a “hold” rating and issued a $35.
00 price objective (up previously from $31.00) on shares of Doximity in a report on Wednesday, August 14th. Canaccord Genuity Group boosted their target price on Doximity from $37.
00 to $40.00 and gave the company a “buy” rating in a research note on Tuesday, August 20th. Barclays raised their price target on Doximity from $31.
00 to $35.00 and gave the stock an “equal weight” rating in a research report on Friday, August 9th. Finally, Wells Fargo & Company lowered Doximity from an “equal weight” rating to an “underweight” rating and dropped their price objective for the company from $27.
00 to $19.00 in a research note on Thursday, July 18th. Check Out Our Latest Stock Analysis on DOCS Insider Buying and Selling Hedge Funds Weigh In On Doximity A number of institutional investors have recently added to or reduced their stakes in DOCS.
LRI Investments LLC purchased a new stake in shares of Doximity in the 1st quarter worth about $27,000. Blue Trust Inc. grew its holdings in Doximity by 621.
4% in the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock worth $37,000 after purchasing an additional 1,193 shares during the period.
Quarry LP increased its stake in shares of Doximity by 101.2% during the second quarter. Quarry LP now owns 1,616 shares of the company’s stock valued at $45,000 after purchasing an additional 131,253 shares in the last quarter.
DekaBank Deutsche Girozentrale purchased a new position in shares of Doximity during the first quarter valued at approximately $46,000. Finally, First Horizon Advisors Inc. lifted its holdings in shares of Doximity by 80.
0% during the second quarter. First Horizon Advisors Inc. now owns 1,710 shares of the company’s stock valued at $48,000 after purchasing an additional 760 shares during the last quarter.
Institutional investors own 87.19% of the company’s stock. Doximity Trading Up 1.
8 % DOCS opened at $40.16 on Wednesday. The stock has a market capitalization of $7.
45 billion, a P/E ratio of 55.78, a PEG ratio of 5.15 and a beta of 1.
27. Doximity has a 12-month low of $19.71 and a 12-month high of $40.
92. The stock has a 50-day moving average price of $32.66 and a 200-day moving average price of $28.
84. Doximity ( NASDAQ:DOCS – Get Free Report ) last issued its earnings results on Thursday, August 8th. The company reported $0.
22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.06.
The business had revenue of $126.68 million during the quarter, compared to analyst estimates of $119.88 million.
Doximity had a return on equity of 19.26% and a net margin of 32.53%.
On average, equities research analysts predict that Doximity will post 0.8 EPS for the current year. About Doximity ( Get Free Report Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States.
The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. Featured Articles Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter .
.
